M 444 (Benazepril 20 mg)

Pill imprint M 444 has been identified as Benazepril hydrochloride 20 mg.

Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 444

Benazepril hydrochloride 20 mg M 444  Front
Benazepril hydrochloride 20 mg M 444  Back
Benazepril hydrochloride 20 mg M 444
Benazepril hydrochloride
Imprint:
M 444
Strength:
20 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0444
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
hypromelloses
polydextrose
polyethylene glycol
corn starch
stearic acid
magnesium silicate
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0146 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)